| Financial Year |
March 31 2023 |
| Monetary Funds |
313,459,489.61 |
| Held-for-trading Financial Assets |
241,113,698.63 |
| Notes Receivable |
-- |
| Accounts Receivable |
109,929,853.10 |
| Advances to Suppliers |
26,477,985.41 |
| Other Receivables |
7,937,238.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
315,729,151.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,038,688.81 |
| Total Current Assets |
1,022,991,675.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
76,699,721.97 |
| Under-construction Projects |
24,619,047.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,795,383.09 |
| R&D expenses |
-- |
| Goodwill |
7,624,875.82 |
| Long-Term Deferred and Prepaid Expenses |
1,505,229.04 |
| Deferred Income Tax Assets |
9,783,638.98 |
| Other Non-Current Assets |
7,205,676.15 |
| Sub-Total of Non-Current Assets |
196,183,611.55 |
| Total Assets |
1,219,175,286.69 |
| Short-Term Loans |
4,004,125.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
76,521,297.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,276,375.33 |
| Taxes Payable |
1,448,202.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,451,563.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,249,420.11 |
| Other Current Liabilities |
326,242.75 |
| Sub-Total of Current Liabilities |
175,706,056.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
370,567.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,352,072.59 |
| Total Liabilities |
180,058,129.11 |
| Paid-In Capital(Or Share Stock) |
136,354,900.00 |
| Capital Surplus |
608,062,024.39 |
| Surplus Reserve |
69,957,253.00 |
| LESS:Treasury Stock |
54,870,440.00 |
| Undistributed Profits |
263,386,699.60 |
| Minority Stockholder's Interest |
2,630,731.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,036,486,425.86 |
| Owner's Equity（Stockholder's Equity） |
1,039,117,157.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,219,175,286.69 |
